DuPont de Nemours, Inc. (DD) stock
Close on Oct 29, 2026Market cap $18.98BP/E 312.4Yield 3.05%
Earnings
DuPont de Nemours's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of DuPont de Nemours's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2026ended Sep 30, 2026 | Nov 5, 2026Expected | – | – | – | – | – |
| Q2 FY2026ended Jun 30, 2026 | Aug 4, 2026before the open | $1.80B | -45.5% | $1.37 | $1.88 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 5, 2026before the open | $1.68B | -45.8% | $0.36 | $0.55 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 10, 2026before the open | $1.70B | -45.2% | -$0.27 | $0.46 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 6, 2025before the open | $3.10B | -3.1% | $0.70 | $1.09 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 5, 2025before the open | $3.30B | +3.1% | $0.54 | $1.12 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 2, 2025before the open | $3.10B | +6.9% | -$1.33 | $1.03 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 11, 2025before the open | $3.10B | +6.9% | -$0.17 | $1.13 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 5, 2024before the open | $3.20B | +3.2% | $1.13 | $1.18 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 31, 2024before the open | $3.20B | +3.2% | $0.40 | $0.97 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 1, 2024before the open | $2.90B | -3.3% | $0.41 | $0.79 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 6, 2024before the open | $2.90B | -6.5% | -$0.72 | $0.87 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 1, 2023before the open | $3.10B | -6.1% | $0.62 | $0.92 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 2, 2023before the open | $3.10B | -6.1% | $0.55 | $0.85 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 2, 2023before the open | $3.00B | -9.1% | $0.58 | $0.84 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 7, 2023before the open | $3.10B | -27.9% | $0.20 | $0.89 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 8, 2022before the open | $3.30B | -23.3% | $0.69 | $0.82 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 2, 2022before the open | $3.30B | – | $0.71 | $0.88 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 3, 2022before the open | $3.30B | – | $0.42 | $0.82 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 8, 2022before the open | $4.30B | – | $0.47 | $1.08 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 2, 2021before the open | $4.30B | – | $0.80 | $1.15 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 3, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 4, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Jan 26, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 29, 2020before the open | – | – | – | – | Filing |
| Q2 FY2020ended Jun 30, 2020 | Jul 30, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
DuPont de Nemours's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net sales | FY2026 | $7.16B – $7.19B | $7.16B – $7.22B | Narrowed | Aug 4, 2026 |
| Net sales | FY2026 | $3.66B – $3.69B | – | New | Aug 4, 2026 |
| organic growthnon-GAAP | FY2026 | +4% | – | New | May 5, 2026 |
| Operating EBITDAnon-GAAP | FY2026 | $1.75B – $1.77B | $1.73B – $1.76B | Raised | Aug 4, 2026 |
| Operating EBITDAnon-GAAP | FY2026 | $890.00M – $910.00M | – | New | Aug 4, 2026 |
| Adjusted EPSnon-GAAP | FY2026 | $7.17 – $7.32 | $2.35 – $2.40 | Raised | Aug 4, 2026 |
| Adjusted EPSnon-GAAP | FY2026 | $3.65 – $3.80 | – | New | Aug 4, 2026 |
| organic growthnon-GAAP | FY2026 | +3% | – | New | Feb 10, 2026 |
Guidance vs results
The last range DuPont de Nemours gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q2 FY2026 | Adjusted EPS | $0.59 | $1.88 | Above range |
| Q2 FY2026 | Revenue | $1.80B | $1.80B | Within range |
| Q1 FY2026 | Adjusted EPS | $0.48 | $0.55 | Above range |
| Q1 FY2026 | Revenue | $1.67B | $1.68B | Above range |
| FY2025 | Adjusted EPS | $1.66 | $3.70Σ4Q | Above range |
| FY2025 | Revenue | $6.84B | $11.20BΣ4Q | Above range |
| Q3 FY2025 | adjusted EPS | $1.15 | $1.09 | Below range |
| Q3 FY2025 | Revenue | $3.32B | $3.10B | Below range |
| Q2 FY2025 | adjusted EPS | $1.05 | $1.12 | Above range |
| Q1 FY2025 | Adjusted EPS (2) | $0.95 | $1.03 | Above range |
| Q1 FY2025 | Revenue | $3.03B | $3.10B | Above range |
| Q4 FY2024 | adjusted EPS | $0.98 | $1.13 | Above range |
| Q4 FY2024 | Revenue | $3.07B | $3.10B | Above range |
| Q3 FY2024 | Adjusted EPS | $1.03 | $1.18 | Above range |
| Q3 FY2024 | Revenue | $3.20B | $3.20B | Within range |
| Q2 FY2024 | Adjusted EPS | $0.84 | $0.97 | Above range |
| Q2 FY2024 | Revenue | $3.03B | $3.20B | Above range |
| Q1 FY2024 | Adjusted EPS (2) | $0.63 – $0.65 | $0.79 | Above range |
| Q1 FY2024 | Revenue | $2.80B | $2.90B | Above range |
| Q3 FY2023 | Adjusted EPS (2)(3) | $0.84 | $0.92 | Above range |
| Q3 FY2023 | Revenue | $3.15B | $3.10B | Below range |
| Q2 FY2023 | Adjusted EPS | $0.84 | $0.85 | Above range |
| Q2 FY2023 | Revenue | $3.02B | $3.10B | Above range |
| Q1 FY2023 | Adjusted EPS | $0.80 | $0.84 | Above range |
| Q1 FY2023 | Revenue | $2.90B | $3.00B | Above range |
| Q3 FY2022 | Adjusted EPS (2) | $0.81 | $0.82 | Above range |
| Q3 FY2022 | Revenue | $3.17B – $3.37B | $3.30B | Within range |
| Q2 FY2022 | Adjusted EPS (2) | $0.70 – $0.80 | $0.88 | Above range |
| Q2 FY2022 | Revenue | $3.20B – $3.30B | $3.30B | Within range |
| Q1 FY2022 | adjusted EPS | $0.94 – $1.00 | $0.82 | Below range |
| Q1 FY2022 | Revenue | $4.20B – $4.30B | $3.30B | Below range |
Guidance history
Every forecast DuPont de Nemours put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 4, 2026 | Operating EBITDA | FY2026 | $1.75B – $1.77B | Raised |
| Aug 4, 2026 | Operating EBITDA | FY2026 | $890.00M – $910.00M | New |
| Aug 4, 2026 | Adjusted EPS | FY2026 | $7.17 – $7.32 | Raised |
| Aug 4, 2026 | Adjusted EPS | FY2026 | $3.65 – $3.80 | New |
| Aug 4, 2026 | Net sales | FY2026 | $7.16B – $7.19B | Narrowed |
| Aug 4, 2026 | Net sales | FY2026 | $3.66B – $3.69B | New |
| May 5, 2026 | Operating EBITDA | FY2026 | $1.73B – $1.76B | Raised |
| May 5, 2026 | Operating EBITDA | Q2 FY2026 | $430.00M | New |
| May 5, 2026 | Adjusted EPS | FY2026 | $2.35 – $2.40 | Raised |
| May 5, 2026 | Adjusted EPS | Q2 FY2026 | $0.59 | New |
| May 5, 2026 | organic growth | FY2026 | +4% | New |
| May 5, 2026 | Net sales | FY2026 | $7.16B – $7.22B | Raised |
| May 5, 2026 | organic sales growth | Q2 FY2026 | +3% | New |
| May 5, 2026 | Net sales | Q2 FY2026 | $1.80B | New |
| Feb 10, 2026 | Operating EBITDA | FY2026 | $1.73B – $1.76B | New |
| Feb 10, 2026 | Operating EBITDA | Q1 FY2026 | $395.00M | New |
| Feb 10, 2026 | Adjusted EPS | FY2026 | $2.25 – $2.30 | New |
| Feb 10, 2026 | Adjusted EPS | Q1 FY2026 | $0.48 | New |
| Feb 10, 2026 | organic growth | FY2026 | +3% | New |
| Feb 10, 2026 | organic growth | Q1 FY2026 | +2% | New |
| Feb 10, 2026 | Net sales | FY2026 | $7.08B – $7.14B | New |
| Feb 10, 2026 | Net sales | Q1 FY2026 | $1.67B | New |
| Nov 6, 2025 | Operating EBITDA | FY2025 | $1.60B | Lowered |
| Nov 6, 2025 | Adjusted EPS | FY2025 | $1.66 | Lowered |
| Nov 6, 2025 | Organic sales growth | FY2025 | +2% | New |
| Nov 6, 2025 | Net sales | FY2025 | $6.84B | Lowered |
| Aug 5, 2025 | Operating EBITDA | FY2025 | $3.36B | New |
| Aug 5, 2025 | operating EBITDA | Q3 FY2025 | $875.00M | New |
| Aug 5, 2025 | Adjusted EPS | FY2025 | $4.40 | New |
| Aug 5, 2025 | adjusted EPS | Q3 FY2025 | $1.15 | New |
| Aug 5, 2025 | Net sales | FY2025 | $12.85B | New |
| Aug 5, 2025 | organic growth | Q3 FY2025 | +3% | New |
| Aug 5, 2025 | net sales | Q3 FY2025 | $3.32B | New |
| May 2, 2025 | Operating EBITDA | Q2 FY2025 | $815.00M | New |
| May 2, 2025 | Operating EBITDA | FY2025 | $3.33B – $3.38B | New |
| May 2, 2025 | adjusted EPS | Q2 FY2025 | $1.05 | New |
| May 2, 2025 | Adjusted EPS | FY2025 | $4.30 – $4.40 | New |
| May 2, 2025 | Net sales | FY2025 | $12.80B – $12.90B | New |
| Feb 11, 2025 | Operating EBITDA (2) | Q1 FY2025 | $760.00M | New |
| Feb 11, 2025 | Adjusted EPS (2) | Q1 FY2025 | $0.95 | New |
| Feb 11, 2025 | Net sales | Q1 FY2025 | $3.03B | New |
| Nov 5, 2024 | operating EBITDA | Q4 FY2024 | $790.00M | New |
| Nov 5, 2024 | operating EBITDA | FY2024 | $3.13B | Raised |
| Nov 5, 2024 | adjusted EPS | Q4 FY2024 | $0.98 | New |
| Nov 5, 2024 | adjusted EPS | FY2024 | $3.90 | Raised |
| Nov 5, 2024 | net sales | Q4 FY2024 | $3.07B | New |
| Nov 5, 2024 | full year net sales | FY2024 | $12.37B | Narrowed |
| Jul 31, 2024 | Operating EBITDA | Q3 FY2024 | $815.00M | New |
| Jul 31, 2024 | Operating EBITDA | FY2024 | $3.06B – $3.11B | Raised |
| Jul 31, 2024 | Adjusted EPS | Q3 FY2024 | $1.03 | New |
| Jul 31, 2024 | Adjusted EPS | FY2024 | $3.70 – $3.80 | Raised |
| Jul 31, 2024 | Net sales | Q3 FY2024 | $3.20B | New |
| Jul 31, 2024 | Net sales | FY2024 | $12.40B – $12.50B | New |
| May 1, 2024 | Operating EBITDA | Q2 FY2024 | $710.00M | New |
| May 1, 2024 | Operating EBITDA | FY2024 | $2.90B – $3.05B | Raised |
| May 1, 2024 | Adjusted EPS | Q2 FY2024 | $0.84 | New |
| May 1, 2024 | Adjusted EPS | FY2024 | $3.45 – $3.75 | Raised |
| May 1, 2024 | Net sales | Q2 FY2024 | $3.03B | New |
| May 1, 2024 | Net sales | FY2024 | $12.10B – $12.40B | Raised |
| Feb 6, 2024 | Operating EBITDA (2) | Q1 FY2024 | $610.00M | Reaffirmed |
| Feb 6, 2024 | Operating EBITDA (2) | FY2024 | $2.80B – $3.00B | New |
| Feb 6, 2024 | Adjusted EPS (2) | Q1 FY2024 | $0.63 – $0.65 | Reaffirmed |
| Feb 6, 2024 | Adjusted EPS (2) | FY2024 | $3.25 – $3.65 | New |
| Feb 6, 2024 | Net sales | Q1 FY2024 | $2.80B | New |
| Feb 6, 2024 | Net sales | FY2024 | $11.90B – $12.30B | New |
| Jan 24, 2024 | Operating EBITDA | Q1 FY2024 | $610.00M | New |
| Jan 24, 2024 | Adjusted EPS | Q1 FY2024 | $0.63 – $0.65 | New |
| Jan 24, 2024 | Net Sales | Q1 FY2024 | $2.80B | New |
| Nov 1, 2023 | Operating EBITDA (2) | FY2023 | $2.98B | Lowered |
| Nov 1, 2023 | Adjusted EPS (2) | FY2023 | $3.45 | Narrowed |
| Nov 1, 2023 | Net sales | FY2023 | $12.17B | Lowered |
| Aug 2, 2023 | Operating EBITDA (2) | Q3 FY2023 | $755.00M | New |
| Aug 2, 2023 | Operating EBITDA (2) | FY2023 | $2.98B – $3.03B | Lowered |
| Aug 2, 2023 | Adjusted EPS (2)(3) | Q3 FY2023 | $0.84 | New |
| Aug 2, 2023 | Adjusted EPS (2)(3) | FY2023 | $3.40 – $3.50 | Lowered |
| Aug 2, 2023 | Net sales | Q3 FY2023 | $3.15B | New |
| Aug 2, 2023 | Net sales | FY2023 | $12.45B – $12.55B | New |
| May 2, 2023 | Operating EBITDA | Q2 FY2023 | $715.00M | New |
| May 2, 2023 | Operating EBITDA | FY2023 | $3.00B – $3.10B | Lowered |
| May 2, 2023 | Adjusted EPS | Q2 FY2023 | $0.84 | New |
| May 2, 2023 | Adjusted EPS | FY2023 | $3.55 – $3.70 | Narrowed |
| May 2, 2023 | Net sales | Q2 FY2023 | $3.02B | New |
| May 2, 2023 | Net sales | FY2023 | $12.30B – $12.50B | Lowered |
| Feb 7, 2023 | Operating EBITDA | Q1 FY2023 | $710.00M | New |
| Feb 7, 2023 | Operating EBITDA | FY2023 | $3.00B – $3.30B | New |
| Feb 7, 2023 | Adjusted EPS | Q1 FY2023 | $0.80 | New |
| Feb 7, 2023 | Adjusted EPS | FY2023 | $3.50 – $4.00 | New |
| Feb 7, 2023 | Net sales | Q1 FY2023 | $2.90B | New |
| Feb 7, 2023 | Net sales | FY2023 | $12.30B – $12.90B | New |
| Nov 8, 2022 | Operating EBITDA | FY2022 | $3.25B | Lowered |
| Nov 8, 2022 | Adjusted EPS | FY2022 | $3.30 | Narrowed |
| Nov 8, 2022 | Net sales | FY2022 | $13.00B | Lowered |
| Aug 2, 2022 | Operating EBITDA (2) | Q3 FY2022 | $810.00M | New |
| Aug 2, 2022 | Operating EBITDA (2) | FY2022 | $3.25B – $3.35B | Lowered |
| Aug 2, 2022 | Adjusted EPS (2) | Q3 FY2022 | $0.81 | New |
| Aug 2, 2022 | Adjusted EPS (2) | FY2022 | $3.27 – $3.43 | Narrowed |
| Aug 2, 2022 | Net sales | Q3 FY2022 | $3.17B – $3.37B | New |
| Aug 2, 2022 | Net sales | FY2022 | $13.00B – $13.40B | Lowered |
| May 3, 2022 | Operating EBITDA (2) | FY2022 | $3.25B – $3.45B | Lowered |
| May 3, 2022 | Operating EBITDA (2) | Q2 FY2022 | $750.00M – $800.00M | New |
| May 3, 2022 | Adjusted EPS (2) | Q2 FY2022 | $0.70 – $0.80 | New |
| May 3, 2022 | Adjusted EPS (2) | FY2022 | $3.20 – $3.50 | Lowered |
| May 3, 2022 | Net sales | Q2 FY2022 | $3.20B – $3.30B | New |
| May 3, 2022 | Net sales | FY2022 | $13.30B – $13.70B | New |
| Feb 8, 2022 | operating EBITDA | FY2022 | $4.30B – $4.50B | New |
| Feb 8, 2022 | operating EBITDA | Q1 FY2022 | $940.00M – $980.00M | New |
| Feb 8, 2022 | adjusted EPS | Q1 FY2022 | $0.94 – $1.00 | New |
| Feb 8, 2022 | adjusted EPS | FY2022 | $4.60 – $4.90 | New |
| Feb 8, 2022 | net sales | Q1 FY2022 | $4.20B – $4.30B | New |
| Feb 8, 2022 | net sales | FY2022 | $17.40B – $17.80B | New |
| Nov 2, 2021 | operating EBITDA | FY2021 | $4.14B – $4.17B | New |
| Nov 2, 2021 | adjusted EPS | FY2021 | $4.18 – $4.22 | New |
| Nov 2, 2021 | net sales | FY2021 | $16.34B – $16.40B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases DuPont de Nemours filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- Update
- Results
- News
- Results
- News
- Results
- Update
- News
- News
- Update
- Update
- Update
- Update